Results 21 to 30 of about 190 (94)

Antibacterial Activity of Kabasura Kudineer on Periodontal Pathogens: An In-vitro Study

Journal of Clinical and Diagnostic Research
Introduction: Antiseptic agents used in periodontics, such as bis-biguanide derivatives (Chlorhexidine - CHX) or essential oils, are primarily chemical substances.
T Jessica Christella, Nizar Ahmed, Vamsi Lavu, S Lavanya, SK Balaji   +4 more
doaj   +2 more sources

In vivo Safety Profiling of Nilavembu Kudineer and Kabasura Kudineer Chooranam in Zebrafish Embryos

Archives of Current Research International
Background: Siddha medicine is one of the most ancient medical systems of India in which Nilavembu Kudineer Chooranam (NKC) and Kabasura Kudineer Chooranam (KKC) were commonly used preparations for various ailments. Objective: This study aimed to assess the teratogenic effects and determine the LC50 values of Nilavembu Kudineer Chooranam (NKC) and ...
Prasath, R. Arun, Yogeswari, R, Mekala, P, Jagadeeswaran, A, Eswarr, M. Ajay, Preethi, K   +5 more
exaly   +3 more sources

“A study to assess the knowledge, attitude and practice regarding Kabasura Kudineer among people residing at Kundrathur”

International Journal of Unani and Integrative Medicine, 2021
Dr. S Tamilselvi, G Indhumathi
exaly   +2 more sources

Screening of Influenza a (H1N1) Neuraminidase Inhibitor for Kabasura Kudineer, Nilavembu Kudineer and the Novel Formulation JACOM [PDF]

, 2021
Due to erratic climate change, vector-borne diseases started flaring up from the second half of the last decade. Siddha medicine has been used as a public health tool to effectively manage chikungunya and dengue in the epidemics that happened in 2008 and 2016. Tamil Nadu government has made enormous efforts to control vector-borne diseases. Due to
SHREE DEVI MS, SATHIYARAJESWARAN P, Mohanasrinivasan V, SUBATHRADEVI C, Ramaswamy RS, Kadarkarai Kanakavalli, Dr SHREE DEVI   +6 more
openaire   +1 more source

Acute Respiratory Distress Syndrome due to COVID-19 in India and efficacy of Indian Siddha drugs - A Trial of Lopinavir-Ritonavir

Journal of Pure and Applied Microbiology, 2022
Novel coronavirus pneumonia (COVID-19) is a respiratory infection caused by infecting lungs and respiratory pathways which has rapidly spread to 216 countries.
P. Rajeshbabu, K.Priadharsini, S.U. Mohammed Riyaz, Manikandan Dhayalan   +3 more
doaj   +1 more source

Novel Drug Design for Treatment of COVID‐19: A Systematic Review of Preclinical Studies

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2022, Issue 1, 2022., 2022
Background. Since the beginning of the novel coronavirus (SARS‐CoV‐2) disease outbreak, there has been an increasing interest in discovering potential therapeutic agents for this disease. In this regard, we conducted a systematic review through an overview of drug development (in silico, in vitro, and in vivo) for treating COVID‐19. Methods.
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, Awat Feizi, Siddhartha Pati   +4 more
wiley   +1 more source

Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2

Journal of Molecular Docking, 2021
The Indian Traditional Medicines System has long used Siddha polyherbal formulations for different viral diseases. The ingredients of these formulas have been proven to be antiviral.
Logesh Kumar Selvaraj, Geethanjali Thayumanavan, Srikanth Jeyabalan, Sugin Lal Jabaris   +3 more
doaj   +1 more source

An open clinical evaluation of selected siddha regimen in expediting the management of COVID-19 –a randomized controlled study

Journal of Ayurveda and Integrative Medicine, 2022
Background: The corona virus disease 2019 (COVID-19), an acute respiratory disease, caused by a novel corona virus (SARS-CoV-2, previously known as 2019-nCoV), obtained worldwide attention.
S.M. Chitra, P. Mallika, N. Anbu, R. Narayanababu, A. Sugunabai, R.S. David Paul Raj, D. Premnath   +6 more
doaj   +1 more source

Pandemic cities: Between mimicry and trickery

, 2020
City &Society, Volume 32, Issue 1, April 2020.
Pushpa Arabindoo
wiley   +1 more source

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects

Phytotherapy Research, Volume 38, Issue 12, Page 5840-5872, December 2024.
ABSTRACT Pulmonary infections have a profound influence on global mortality rates. Medicinal plants offer a promising approach to address this challenge, providing nontoxic alternatives with higher levels of public acceptance and compliance, particularly in regions where access to conventional medications or diagnostic resources may be limited ...
Joyce Siaw Syuen Ho, Teh Li Ping, Keshav Raj Paudel, Tammam El Sherkawi, Gabriele De Rubis, Stewart Yeung, Philip M. Hansbro, Brian Gregory George Oliver, Dinesh Kumar Chellappan, Keng Pei Sin, Kamal Dua   +10 more
wiley   +1 more source